David W. Cope

David W. Cope

Auto-generated profile, based on publicly available information

David W. Cope

MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, Oxford University, Mansfield Road, Oxford OX1 3TH, UK

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2009 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
DBDelia Belelli
Delia Belelli
NHNeil L. Harrison
Neil L. Harrison
JMJamie Maguire
Jamie Maguire
RMRobert L. Macdonald
Robert L. Macdonald
MWMatthew C. Walker
Matthew C. Walker
DCDavid W. Cope
David W. Cope
GABA is the principal inhibitory neurotransmitter in the CNS and acts via GABAAand GABABreceptors. Recently, a novel form of GABAAreceptor-mediated inhibition, termed “tonic” inhibition, has been described. Whereas synaptic GABAAreceptors underlie classical “phasic” GABAAreceptor-mediated inhibition (inhibitory postsynaptic currents), tonic GABAAreceptor-mediated inhibition results from the activation of extrasynaptic receptors by low concentrations of ambient GABA. Extrasynaptic GABAAreceptors are composed of receptor subunits that convey biophysical properties ideally suited to the generation of persistent inhibition and are pharmacologically and functionally distinct from their synaptic counterparts. This mini-symposium review highlights ongoing work examining the properties of recombinant and native extrasynaptic GABAAreceptors and their preferential targeting by endogenous and clinically relevant agents. In addition, it emphasizes the important role of extrasynaptic GABAAreceptors in GABAergic inhibition throughout the CNS and identifies them as a major player in both physiological and pathophysiological processes.

22 November 2009 in Nature Medicine
Verified
Journal Article
Open access
PDF file
DCDavid W Cope
David W Cope
Giuseppe Di GiovanniGiuseppe Di Giovanni
Giuseppe Di Giovanni
SFSarah J Fyson
Sarah J Fyson
GOGergely Orbán
Gergely Orbán
AEAdam C Errington
Adam C Errington
VCVincenzo Crunelli
Vincenzo Crunelli
Contrary to the widely held view that impaired γ-aminobutyric acid (GABA)-mediated neurotransmission underlies epileptic activity, extrasynaptic GABA-dependent thalamocortical inhibition caused by reduced GABA uptake is reported to be increased in diverse models of absence seizures. The cellular mechanisms underlying typical absence seizures, which characterize various idiopathic generalized epilepsies, are not fully understood, but impaired γ-aminobutyric acid (GABA)-ergic inhibition remains an attractive hypothesis. In contrast, we show here that extrasynaptic GABAA receptor–dependent 'tonic' inhibition is increased in thalamocortical neurons from diverse genetic and pharmacological models of absence seizures. Increased tonic inhibition is due to compromised GABA uptake by the GABA transporter GAT-1 in the genetic models tested, and GAT-1 is crucial in governing seizure genesis. Extrasynaptic GABAA receptors are a requirement for seizures in two of the best characterized models of absence epilepsy, and the selective activation of thalamic extrasynaptic GABAA receptors is sufficient to elicit both electrographic and behavioral correlates of seizures in normal rats. These results identify an apparently common cellular pathology in typical absence seizures that may have epileptogenic importance and highlight potential therapeutic targets for the treatment of absence epilepsy.

14 December 2005 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
DCDavid W. Cope
David W. Cope
SHStuart W. Hughes
Stuart W. Hughes
VCVincenzo Crunelli
Vincenzo Crunelli
Tonic GABAAreceptor-mediated inhibition is typically generated byδ subunit-containing extrasynaptic receptors. Because the δ subunit is highly expressed in the thalamus, we tested whether thalamocortical (TC) neurons of the dorsal lateral geniculate nucleus (dLGN) and ventrobasal complex exhibit tonic inhibition. Focal application of gabazine (GBZ) (50 μm) revealed the presence of a 20 pA tonic current in 75 and 63% of TC neurons from both nuclei, respectively. No tonic current was observed in GABAergic neurons of the nucleus reticularis thalami (NRT). Bath application of 1μmGABA increased tonic current amplitude to ∼70 pA in 100% of TC neurons, but it was still not observed in NRT neurons. In dLGN TC neurons, the tonic current was sensitive to low concentrations of the δ subunit-specific receptor agonists allotetrahydrodeoxycorticosterone (100 nm) and 4,5,6,7-tetrahydroisoxazolo[5,4-c]-pyridin-3-ol (THIP) (100 nm) but insensitive to the benzodiazepine flurazepam (5 μm). Bath application of low concentrations of GBZ (25–200 nm) preferentially blocked the tonic current, whereas phasic synaptic inhibition was primarily maintained. Under intracellular current-clamp conditions, the preferential block of the tonic current with GBZ led to a small depolarization and increase in input resistance. Using extracellular single-unit recordings, block of the tonic current caused the cessation of low-threshold burst firing and promoted tonic firing. Enhancement of the tonic current by THIP hyperpolarized TC neurons and promoted burst firing. Thus, tonic current in TC neurons generates an inhibitory tone. Its modulation contributes to the shift between different firing modes, promotes the transition between different behavioral states, and predisposes to absence seizures.

24 June 2005 in European Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
DCD. W. Cope
D. W. Cope
CHC. Halbsguth
C. Halbsguth
TKT. Karayannis
T. Karayannis
PWP. Wulff
P. Wulff
FFFrancesco Ferraguti
Francesco Ferraguti
MCM. Capogna
M. Capogna

11 May 2004 in Neuropharmacology
Verified
Journal Article
Closed access
DCD.W. Cope
D.W. Cope
PWP. Wulff
P. Wulff
AOA. Oberto
A. Oberto
MAM.I. Aller
M.I. Aller
MCM. Capogna
M. Capogna
WWW. Wisden
W. Wisden